Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.5935EUR
−257.52 MEUR
133.86 MEUR
93.37 M
About FibroGen, Inc
Sector
CEO
Thane Wettig
Headquarters
San Francisco
Website
Founded
1993
FIGI
BBG007K5JY14
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange FIBROGEN INC. DL-,01 stocks are traded under the ticker 1FG.
Yes, you can track FIBROGEN INC. DL-,01 financials in yearly and quarterly reports right on TradingView.
FIBROGEN INC. DL-,01 is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
1FG earnings for the last quarter are −0.15 EUR per share, whereas the estimation was −0.30 EUR resulting in a 50.00% surprise. The estimated earnings for the next quarter are −0.28 EUR per share. See more details about FIBROGEN INC. DL-,01 earnings.
FIBROGEN INC. DL-,01 revenue for the last quarter amounts to 47.28 M EUR, despite the estimated figure of 32.36 M EUR. In the next quarter, revenue is expected to reach 31.29 M EUR.
1FG net income for the last quarter is −14.51 M EUR, while the quarter before that showed −30.52 M EUR of net income which accounts for 52.45% change. Track more FIBROGEN INC. DL-,01 financial stats to get the full picture.
No, 1FG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 486.00 employees. See our rating of the largest employees — is FIBROGEN INC. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FIBROGEN INC. DL-,01 EBITDA is −131.82 M EUR, and current EBITDA margin is −175.48%. See more stats in FIBROGEN INC. DL-,01 financial statements.
Like other stocks, 1FG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FIBROGEN INC. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.